Related Experiment Video
Updated: Aug 19, 2026

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
Published on: April 10, 2026
Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Data from a randomized
K Thies-Flechtner1, B Müller-Oerlinghausen, W Seibert
1Department of Psychiatry, Freie Universität Berlin, Germany.
Abstract:
Recent findings have indicated that lithium treatment markedly reduces suicide risk in major affective disorders. To compare the effect of lithium with carbamazepine and amitriptyline, suicidal behavior was analyzed during the randomized prospective long-term MAP study (N = 378; duration 2.5 years). Of the nine suicides and five attempted suicides, none took place during lithium treatment. The findings support the view that lithium has a specific antisuicidal effect over and above its prophylactic benefit.
Related Concept Videos
The Placebo Effect
Psychosis: Goals of Pharmacotherapy
Antidepressant Drugs: MAOIs and Other Agents
Therapeutic Drug Monitoring: Affecting Factors